Literature DB >> 5545614

Amantadine for dyskinesia tarda.

S Vale, M A Espejel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5545614     DOI： 10.1056/nejm197103252841216

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Rapid response of disabling tardive dyskinesia to amantadine: a case report.

Authors:  Gaurav Jain
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors:  Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 3.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

Review 4.  Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?

Authors:  Sarah Marmol; Matthew Feldman; Carlos Singer; Jason Margolesky
Journal:  CNS Drugs       Date:  2021-10-14       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.